Concepedia

Adaptive Pathway Design

Adaptive Pathway Design is an abbreviated approval pathway strategy that iteratively refines patient access to medical interventions based on accumulating evidence, distinguishing itself from traditional regulatory approaches through its proactive incorporation of real-world data and conditional progression criteria.

7

Publications

393

Citations

64

Authors

46

Institutions

Publications per year

2017–2026

2

Parents

Publications

7

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

H‐G Eichler, LG Baird, Richard Barker et al. · Clinical Pharmacology & Therapeutics · 2015 · 187 citations · Full text

, , +15

Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe

Jacoline C. Bouvy, Claudine Sapède, Sarah Garner · Frontiers in Pharmacology · 2018 · 71 citations · Full text

, , +12

“Adaptive pathways” to drug authorisation: adapting to industry?

Courtney Davis, Joel Lexchin, Tom Jefferson et al. · BMJ · 2016 · 45 citations · Full text

, , +8

A Holistic Environment for the Design and Execution of Self-Adaptive Clinical Pathways

Ioannis E. Skitsas, Gregoris Mentzas · IEEE Transactions on Information Technology in Biomedicine · 2010 · 36 citations · Full text

, , +16

Real options, multi-objective optimization and the development of dynamically robust adaptive pathways

Nishtha Manocha, Vladan Babovic · Environmental Science & Policy · 2018 · 27 citations

, , +15

1–5 of 7

Authors

64

  1. ML
    Murray Lumpkin

    Gates Foundation, United States

    2 publications · 203 citations

    2

    h-index

  2. CL
    Carole Longson

    National Institute for Health and Care Excellence, United Kingdom

    2 publications · 198 citations

    2

    h-index

  3. SG
    Sarah Garner

    National Institute for Health and Care Excellence, United Kingdom

    2 publications · 87 citations

    2

    h-index

  4. AH
    Anton Hoos

    Amgen (Switzerland), Switzerland

    2 publications · 203 citations

    2

    h-index

  5. GH
    Gigi Hirsch

    Massachusetts Institute of Technology, United States

    2 publications · 203 citations

    2

    h-index

1–5 of 64

Institutions

46

  1. National Institute for Health and Care Excellence

    Manchester, United Kingdom

    4 h-index

    9 publications

    576 citations

  2. Gates Foundation

    Seattle, United States

    2 h-index

    2 publications

    203 citations

  3. London School of Hygiene & Tropical Medicine

    London, United Kingdom

    1 h-index

    1 publications

    45 citations

  4. Medical University of Vienna

    Vienna, Austria

    1 h-index

    1 publications

    187 citations

  5. Ubitech (Greece)

    Athens, Greece

    1 h-index

    1 publications

    36 citations

  6. Amgen (Switzerland)

    Zug, Switzerland

    1 h-index

    1 publications

    16 citations

  7. Medicines Evaluation Board

    Utrecht, Netherlands

    1 h-index

    1 publications

    187 citations

  8. Janssen (Belgium)

    Beerse, Belgium

    1 h-index

    1 publications

    16 citations

1–8 of 46

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 2 publications · 198 citations

    2

    h-index

  2. Environmental Science & Policy

    1 publications · 27 citations

    1

    h-index

  3. 1

    h-index

  4. Frontiers in Pharmacology

    1 publications · 71 citations

    1

    h-index

  5. BMJ

    1 publications · 45 citations

    1

    h-index

1–5